[(1,2,5,6-η)-1,5-Cyclooctadiene][(4S)-2-[(5R)-6-(diphenylphosphino-κP)spiro[4.4]nona-1,6-dien-1-yl]-4,5-dihydro-4-phenyloxazole-κN3]-(-)-Iridium(I) Tetrakis[3,5-bis(trifluoromethyl)phenyl]borate
98%
- Product Code: 57548
CAS:
1195511-59-1
| Molecular Weight: | 1613.10 g./mol | Molecular Formula: | C₇₀H₅₂BF₂₄IrNOP |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | 172-174 °C | Boiling Point: | |
| Density: | Storage Condition: | 2-8°C |
Product Description:
This complex is primarily utilized in asymmetric catalysis, particularly in hydrogenation reactions. Its chiral structure makes it highly effective for producing enantioselective products, which are crucial in the synthesis of pharmaceuticals and fine chemicals. The ligand system, combined with the iridium center, allows for precise control over the stereochemistry of the reaction, enabling the production of specific enantiomers with high selectivity. This is especially valuable in the development of active pharmaceutical ingredients (APIs) where the correct chirality is essential for biological activity. Additionally, the presence of the tetrakis[3,5-bis(trifluoromethyl)phenyl]borate anion enhances the solubility and stability of the catalyst in various organic solvents, making it versatile for different reaction conditions. Its application extends to the synthesis of complex organic molecules, where high enantiomeric excess and yield are desired.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.010 | 10-20 days | Ft256,208.29 |
+
-
|
[(1,2,5,6-η)-1,5-Cyclooctadiene][(4S)-2-[(5R)-6-(diphenylphosphino-κP)spiro[4.4]nona-1,6-dien-1-yl]-4,5-dihydro-4-phenyloxazole-κN3]-(-)-Iridium(I) Tetrakis[3,5-bis(trifluoromethyl)phenyl]borate
This complex is primarily utilized in asymmetric catalysis, particularly in hydrogenation reactions. Its chiral structure makes it highly effective for producing enantioselective products, which are crucial in the synthesis of pharmaceuticals and fine chemicals. The ligand system, combined with the iridium center, allows for precise control over the stereochemistry of the reaction, enabling the production of specific enantiomers with high selectivity. This is especially valuable in the development of active pharmaceutical ingredients (APIs) where the correct chirality is essential for biological activity. Additionally, the presence of the tetrakis[3,5-bis(trifluoromethyl)phenyl]borate anion enhances the solubility and stability of the catalyst in various organic solvents, making it versatile for different reaction conditions. Its application extends to the synthesis of complex organic molecules, where high enantiomeric excess and yield are desired.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
Ft0.00
Ft0.00
Total :